Publications by authors named "Angelo Paredes"

Claim this Profile
P
Portal Hypertensive Colopathy: Diagnostic Challenges and Management in Cirrhosis.
Jiasheng Henry Guo, Angelo H Paredes

Curr Gastroenterol Rep· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality measures in pre-liver transplant care by the Practice Metrics Committee of the American Association for the Study of Liver Diseases.
Mayur Brahmania, Alexander Kuo, Elliot B Tapper, Michael L Volk, Jennifer M Vittorio, Angelo H Paredes

Hepatology· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Cardiac Dysfunction in Biopsy-proven Nonalcoholic Fatty Liver Disease.
Peter C Johnson, Anthony A Cochet, Rosco S Gore, Stephen A Harrison, John P Magulick, Angelo H Paredes

Korean J Gastroenterol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective evaluation of the prevalence of non-alcoholic fatty liver disease and steatohepatitis in a large middle-aged US cohort.
Stephen A Harrison, Samer Gawrieh, Katharine Roberts, Christopher J Lisanti, Ryan B Schwope, Angelo H Paredes

J Hepatol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Aldafermin, an Engineered FGF19 Analog, in a Randomized, Double-Blind, Placebo-Controlled Trial of Patients With Nonalcoholic Steatohepatitis.
Stephen A Harrison, Guy Neff, Cynthia D Guy, Mustafa R Bashir, Angelo H Paredes

Gastroenterology· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The transcontinental variability of nonalcoholic fatty liver disease.
Claudia P Oliveira, Angelo Paredes, Mohammed Siddiqui, Lawrence Serfaty, Abhijit Chowdhury

Hepatoma Res· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NGM282 Improves Liver Fibrosis and Histology in 12 Weeks in Patients With Nonalcoholic Steatohepatitis.
Stephen A Harrison, Stephen J Rossi, Angelo H Paredes, James F Trotter, Mustafa R Bashir

Hepatology· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study.
Philip N Newsome, Magali Sasso, Jonathan J Deeks, Angelo Paredes, Jérôme Boursier

Lancet Gastroenterol Hepatol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assay validation and clinical performance of chronic inflammatory and chemokine biomarkers of NASH fibrosis.
Sumit Kar, Sabina Paglialunga, Sharon H Jaycox, Rafiqul Islam, Angelo H Paredes

PLoS One· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
One-hour Recovery Time in Subjects Undergoing Percutaneous Liver Biopsy: A Quality Improvement and Patient Safety Project.
Billy-Joe Liane, Guy Dooley, Sonali Sarkar, Angelo Paredes, Amilcar L Morales-Cardona

Cureus· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rosuvastatin improves the FGF19 analogue NGM282-associated lipid changes in patients with non-alcoholic steatohepatitis.
Mary E Rinella, James F Trotter, Manal F Abdelmalek, Angelo H Paredes, Margery A Connelly

J Hepatol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utility and variability of three non-invasive liver fibrosis imaging modalities to evaluate efficacy of GR-MD-02 in subjects with NASH and bridging fibrosis during a phase-2 randomized clinical trial.
Stephen A Harrison, Andrea Dennis, Martine M Fiore, Matt D Kelly, Catherine J Kelly, Angelo H Paredes

PLoS One· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NGM282 for treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.
Stephen A Harrison, Mary E Rinella, Manal F Abdelmalek, James F Trotter, Angelo H Paredes

Lancet· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gastric Outlet Obstruction due to Gastrointestinal Amyloidosis.
Jared A Cohen, Jong An, Alexander W Brown, Darren Spearman, Angelo Paredes

J Gastrointest Surg· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utility of evaluating HCV in an uninsured population.
Indira Donepudi, Angelo Paredes, Sarah Hubbard, Chadi Awad, Richard K Sterling

Dig Dis Sci· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of nonalcoholic fatty liver disease: Role of dietary modification and exercise.
Angelo H Paredes, Dawn M Torres, Stephen A Harrison

Clin Liver Dis (Hoboken)· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonalcoholic fatty liver disease.
Angelo H Paredes, Dawn M Torres, Stephen A Harrison

Clin Liver Dis· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiology corner. Case 34: Aspergilloma.
Massimo Federico, Bridget Cunningham, Angelo Paredes, Dara Lee, Les Folio

Mil Med· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug-induced liver injury in 2007.
William Norris, Angelo H Paredes, James H Lewis

Curr Opin Gastroenterol· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Terbinafine-induced acute autoimmune hepatitis in the setting of hepatitis B virus infection.
Angelo H Paredes, James H Lewis

Ann Pharmacother· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis